Invasive strategy improves outcome in elderly with ACS

Invasive strategy improves outcome in elderly with ACS

(HealthDay)—An invasive strategy using coronary angiography results in a better outcome in elderly patients with non-ST-segment elevation acute coronary syndrome (ACS), according to research published in the March 1 issue of The American Journal of Cardiology.

Gennaro Galasso, M.D., Ph.D., of Federico II University in Naples, Italy, and colleagues conducted an "as-treated" subanalysis of the Italian Elderly ACS trial to compare the outcome for patients receiving with as needed (182 patients), or conservative treatment (CT) with medical therapy (131 patients), during initial hospitalization. The outcome was the composite of death, myocardial infarction (MI), disabling stroke, and repeat hospital stay for cardiovascular causes or bleeding within one year.

The researchers found that the composite outcome occurred in more patients in the CT group (40.5 percent) than in the invasive treatment group (24.7 percent; hazard ratio, 0.56; P = 0.003). Compared with the CT group, the invasive treatment group had lower rates of MI (6 versus 13 percent; hazard ratio, 0.43; P = 0.034) and the aggregate of death and MI (14.3 versus 27.5 percent; hazard ratio, 0.48; P = 0.004).

"In conclusion, with non-ST-segment elevation treated invasively experienced significantly better survival free from the composite of all-cause mortality, nonfatal MI, disabling stroke, and repeat hospitalization for cardiovascular causes or bleeding," the authors write.


Explore further

Revascularization cuts mortality, MACE in coronary CTO

More information: Abstract
Full Text (subscription or payment may be required)
Journal information: American Journal of Cardiology

Copyright © 2015 HealthDay. All rights reserved.

Citation: Invasive strategy improves outcome in elderly with ACS (2015, March 2) retrieved 20 November 2019 from https://medicalxpress.com/news/2015-03-invasive-strategy-outcome-elderly-acs.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
4 shares

Feedback to editors

User comments